We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nerve Damage May Occur After Weight-Loss Surgery

By HospiMedica staff writers
Posted on 12 Jun 2007
A new study shows patients can develop potentially disabling neurologic complications after gastric bypass surgery performed to treat morbid obesity. More...


Researchers from the University of Arkansas for Medical Science (Little Rock, AR, USA) described 26 cases of neurologic problems that occurred in gastric bypass patients. The neurologic complications affected most regions of the nervous system: encephalopathy, optic neuropathy, myelopathy, and others. Myelopathy, or muscular disorder, was the most frequent and disabling problem, with symptoms beginning about a decade after surgery; the spinal cord typically is affected, resulting in falling, extreme coordination and gait problems, and severe spasticity. Except for vitamin B12 and copper deficiencies in patients with myelopathy, the researchers could not correlate specific nutritional deficiencies to the neurologic complications.

While restoring nutritional deficiencies--which included lack of vitamin B12, thiamine, or copper--helped patients, many continued to have symptoms for months, while symptoms remained permanent in some patients. The researchers suggest that steps should be taken to help prevent gastric bypass patients from developing these problems in the first place by advising them to take vitamin and mineral supplements and to avoid severe and rapid weight loss. The study was published in the May 22, 2007 edition of the journal Neurology.

"Many of our patients were not instructed to take vitamin supplements, and postoperative follow-up visits with medical nutritionists were not emphasized,” said lead author Dr. Katalin Juhasz-Pocsine and colleagues.


Related Links:
University of Arkansas for Medical Science

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.